Washington, D.C. 20549


Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Nunn Jason Raleigh

(Last) (First) (Middle)


(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Dermira, Inc. [ DERM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/12/2019 M 3,000 A $0.00 6,000 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Common Stock (1) 06/12/2019 M 3,000 (2) (1) Common Stock 3,000 $0.00 0.00 D
Explanation of Responses:
1. Each RSU represents a contingent right to receive one share of DERM common stock.
2. The RSU, which was granted on June 12, 2018, fully vested on June 12, 2019.
/s/ Andrew L Guggenhime as attorney-in-fact 06/14/2019
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

	KNOW ALL MEN BY THESE PRESENTS, that the undersigned hereby 
constitutes and appoints Andrew Guggenhime, Valerie Barnett, 
Douglas Cogen, Michael Brown, Katherine Duncan, Jennifer 
Hitchcock, Nanette Agustines and Winston Macaraeg, and each of 
them, as his or her true and lawful attorney-in-fact to:

      	(1)	execute for and on behalf of the undersigned, in 
the undersigned's capacity as a representative of Dermira, Inc. 
(the "Company"), any and all Form ID, or Form 3, 4 or 5 reports 
and any amendments thereto required to be filed by the 
undersigned in accordance with Section 16(a) of the Securities 
Exchange Act of 1934 (the "Exchange Act") and the rules 
thereunder with respect to transactions in the Company's 
      	(2)	do and perform any and all acts for and on behalf 
of the undersigned which may be necessary or desirable to 
complete and execute any such Form ID, or Form 3, 4 or 5 report 
and any amendments thereto and timely file such report with the 
U.S. Securities and Exchange Commission and any stock exchange 
or similar authority; and
      	(3)	take any other action of any type whatsoever in 
connection with the foregoing which, in the opinion of such 
attorney-in-fact, may be of benefit to, in the best interest of, 
or legally required
 by, the undersigned, it being understood 
that the documents executed by such attorney-in-fact on behalf 
of the undersigned, pursuant to this Power of Attorney, shall be 
in such form and shall contain such terms and conditions as such 
attorney-in-fact may approve in his or her discretion.
      The undersigned hereby grants to each such attorney-in-fact 
full power and authority to do and perform each and every act 
and thing whatsoever requisite, necessary, and proper to be done 
in the exercise of any of the rights and powers herein granted, 
as fully to all intents and purposes as the undersigned might or 
could do if personally present, with full power of substitution 
or revocation, hereby ratifying and confirming all that such 
attorney-in-fact, or his or her substitute or substitutes, shall 
lawfully do or cause to be done by virtue of this Power of 
Attorney and the rights and powers herein granted.  The 
undersigned acknowledges that no such attorney-in-fact, in 
serving in such capacity at the request of the undersigned, is 
hereby assuming, nor is the Company hereby assuming, any of the 
undersigned's responsibilities to comply with Section 16 of the 
Exchange Act.
      This Power of Attorney shall remain in full force and 
effect until the undersigned is no longer required to file Form 
3, 4 or 5 reports with respect to the undersigned's holdings of 
and transactions in securities issued by the Company, unless 
earlier revoked by the undersigned in a signed writing delivered 
to the foregoing attorneys-in-fact.
      IN WITNESS WHEREOF, the undersigned has caused this Power 
of Attorney to be executed as of this 10th day of June, 2019.

/s/ Jake R. Nunn